Short answer · Medically reviewed summary · Last updated: 2026-04-07
Kabuki syndrome does not have a unique, specific code in the ICD-9-CM or ICD-10-CM classification systems; instead, it is typically coded under "Other specified congenital malformation syndromes" (ICD-10 code Q87.89). Because Kabuki syndrome is a rare multisystem disorder, clinicians often use these broader category codes to capture the clinical presentation for insurance and administrative purposes. What is the clinical significance of Kabuki syndrome? Kabuki syndrome is a rare genetic disorder characterized by distinctive facial features, growth delays, intellectual disability, and skeletal abnormalities.
Kabuki syndrome does not have a unique, specific code in the ICD-9-CM or ICD-10-CM classification systems; instead, it is typically coded under "Other specified congenital malformation syndromes" (ICD-10 code Q87.89). Because Kabuki syndrome is a rare multisystem disorder, clinicians often use these broader category codes to capture the clinical presentation for insurance and administrative purposes.
Kabuki syndrome is a rare genetic disorder characterized by distinctive facial features, growth delays, intellectual disability, and skeletal abnormalities. First described in Japan in 1981, Kabuki syndrome is estimated to occur in approximately 1 in 32,000 to 1 in 86,000 newborns. The condition is multisystemic, which means it can affect nearly every organ system, necessitating a coordinated approach from a multidisciplinary medical team. Within the DiseaseMaps community, 50 individuals living with Kabuki syndrome have connected to share their unique experiences, highlighting the importance of peer support in managing this complex diagnosis.
Diagnosis of Kabuki syndrome is primarily clinical, based on a combination of characteristic facial features—such as long palpebral fissures with eversion of the lateral third of the lower eyelid—and developmental findings. Confirmatory molecular genetic testing is essential, as mutations in the KMT2D gene (associated with Kabuki syndrome type 1) or the KDM6A gene (associated with Kabuki syndrome type 2) are identified in a significant subset of cases. Because there is no dedicated ICD-10 code for Kabuki syndrome, medical billing often utilizes the following approaches:
In most cases, Kabuki syndrome occurs as a de novo (sporadic) mutation, meaning it is not inherited from either parent. However, KMT2D-related Kabuki syndrome is inherited in an autosomal dominant pattern, and KDM6A-related Kabuki syndrome follows an X-linked dominant inheritance pattern. Genetic counseling is strongly recommended for families to understand the recurrence risk, which is generally low for unaffected parents but can be significant depending on the specific genetic findings.
Receiving a diagnosis of a rare condition like Kabuki syndrome can be overwhelming for families. It is common to experience a range of emotions, from relief at finally having a name for the symptoms to anxiety about the future. Connecting with others through platforms like DiseaseMaps.org can help reduce feelings of isolation. Focusing on early intervention therapies—such as physical, occupational, and speech therapy—can significantly improve developmental outcomes for children living with Kabuki syndrome.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.